" /> Cesnicabtagene Autoleucel - CISMeF





Preferred Label : Cesnicabtagene Autoleucel;

NCIt synonyms : Autologous Differentiated Anti-BCMA CAR T-cells ARI0002h; CARTBCMA ARI0002h; Differentiated Anti-BCMA Autologous CAR T Cells ARI0002h;

NCIt definition : A preparation of adult human differentiated autologous T-lymphocytes that have been ex vivo expanded and transduced with a genetically-engineered lentiviral vector (LV) expressing a chimeric antigen receptor (CAR) specific for the tumor-associated antigen (TAA) human B-cell maturation antigen (BCMA; tumor necrosis factor receptor superfamily member 17; TNFRSF17) fused to the co-stimulatory domain of 4-1BB (CD137) and the CD3-zeta (CD3z) T-cell signaling domain, with potential immunostimulating and antineoplastic activities. Upon administration, cesnicabtagene autoleucel specifically recognize and induce selective toxicity in BCMA-expressing tumor cells. BCMA, a tumor-specific antigen and a receptor for both a proliferation-inducing ligand (APRIL) and B-cell activating factor (BAFF), is a member of the tumor necrosis factor receptor superfamily (TNFRSF) and plays a key role in plasma cell survival. BCMA is found on the surfaces of plasma cells and overexpressed on malignant plasma cells.;

UNII : DCY3M5W6TC;

Molecule name : ARI 0002h; ARI-0002h;

NCI Metathesaurus CUI : CL1642550;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
10/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.